ScreenerHero

SPTXSeaport Therapeutics Inc. Common Stock

NAS · US · Healthcare · Biotechnology · seaporttx.com
24.31USD-0.45%Mkt Cap: 1.30B $P/E: —

Seaport Therapeutics, Inc., a clinical-stage therapeutics company, focuses on inventing and developing new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. It is leverag…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap1.30B $
Enterprise Value1.02B $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-74.88M $
Revenue/Share—
Last Price24.31 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees58
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-9.33
PEG—
EV/EBITDA-7.08
EV/Revenue—
P/S—
P/B-0.54
EPS (TTM)-2.49
EPS (Forward)-2.58
52W Range
14.8582% of range26.32
52W High26.32 USD
52W Low14.85 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE80.91%
ROA-30.07%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-77.94M $
CapEx (TTM)356.00K $
FCF Margin—
FCF Yield—
Net Debt-268.29M $
Net Debt/EBITDA1.87
Balance Sheet
Debt/Equity-0.05
Current Ratio18.00
Quick Ratio17.75
Book Value/Sh-44.5490 USD
Cash/Share5.106 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)38.00 USD
Upside (mean)+56.3%
Target Range30.00 USD – 50.00 USD
$30.00+56.3% to mean$50.00
# Analysts5
Ownership
Shares Out.53.53M
Float18.43M
Insiders35.06%
Institutions69.95%
Short Interest
Short Ratio21.2d
Short % Float5.41%
Short % Out.5.15%
Shares Short2.76M
Short (prev mo.)2.78M
Technical
SMA 5020.84 (+16.6%)
SMA 20019.46 (+24.9%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)106.30K
Avg Vol (10d)132.85K
Technical Indicators
RSI (14)66.3
MACD1.1126
MACD Signal0.9449
MACD Hist.+0.1678
BB Upper25.65 USD
BB Middle22.32 USD
BB Lower18.99 USD
BB Width29.83%
ATR (14)1.483 USD
Vol Ratio (20d)0.73x